SFM
CUE icon

Sphera Funds Management’s Cue Biopharma CUE Stock Holding History

Sphera Funds Management’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,667
Closed -$422K – 90
2019
Q3 		$422K Hold
1,667
– – 0.07% 77
2019
Q2 		$450K Hold
1,667
– – 0.06% 84
2019
Q1 		$387K Hold
1,667
– – 0.04% 99
2018
Q4 		$235K Buy
1,667
+1,000
+150% +$181K 0.03% 97
2018
Q3 		$181K Buy
+667
New +$193K 0.02% 113

Other funds holding CUE

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return

Sphera Funds Management's CUE Position: Q4 2019 in Review

Sphera Funds Management sold out of Cue Biopharma (CUE) in Q4 2019, closing a stake of 1,667 shares — an estimated $422K sold.

Sphera Funds Management first reported a position in CUE in Q3 2018 and held it in 5 quarters. The position peaked at $450K in Q2 2019. 63 funds tracked by Wall St. Rank hold CUE as of Q4 2019.

  • Sphera Funds Management reported no remaining Cue Biopharma position as of Q4 2019 after selling out during the quarter.
  • Sphera Funds Management sold 1,667 Cue Biopharma shares in Q4 2019, an estimated $422K.
  • Sphera Funds Management first reported a position in Cue Biopharma in Q3 2018 and held it in 5 quarters.
  • Sphera Funds Management's Cue Biopharma position peaked at $450K in Q2 2019.
  • 63 funds tracked by Wall St. Rank held Cue Biopharma as of Q4 2019.

Based on Sphera Funds Management's 13F filing for Q4 2019, filed 13 Feb 2020.